Home » Topics » BioWorld Science

BioWorld Science
RSS

TRIGR Therapeutics and ABL Bio collaborate in immuno-oncology

July 3, 2018

Advicenne reports preliminary phase III extension study results for ADV-7103

July 3, 2018

Phase I/II data presented for FT-2102, a mutant IDH1 inhibitor, in AML or MDS patients

July 3, 2018

Compugen announces IND clearances for BAY-1905254 and COM-701

July 3, 2018

FDA grants fast track designation to CUTX-101 for treatment of classic Menkes disease

July 3, 2018

FDA awards regenerative medicine advanced therapy designation to romyelocel-L

July 3, 2018

Ocugen initiates first pivotal trial of OCU-300 for ocular graft-versus-host disease

July 3, 2018

Cereno reports results from first clinical study of CS-1

July 3, 2018

Bacteriophages adjuvant therapy tested in patients with severe staphylococcal sepsis

July 3, 2018

Gazyva receives approval in Japan

July 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...